Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by longterm56on Apr 19, 2021 7:55am

125 Views

Post# 33020579

Boeing shareholders will weigh need for more changes to boar

Seems like our discussions are appropriate and within our shareholder's rights. We need a "Shareholdes Advisory Committee" (Wino!!) and possibly a "proxy advisory firm" to dig out the details.

-LT

https://www.foxbusiness.com/industrials/boeing-shareholders-will-weigh-need-for-more-changes-to-board

<< Previous

Bullboard Posts

Next >>

B2Gold stock buckles under news of labour strike in Mali